24 Hrs
Source:
المصري اليوم
_1777352244987_250242181.png&w=64&q=75){kind=small}
_1777352142843_145525226.png&w=64&q=75){kind=small}
Ma'moun Zakaria's illness and ALS treatment progress
A new and effective gene therapy has been developed that can target a rare mutation causing Amyotrophic Lateral Sclerosis (ALS), a neurological disease that leads to the death of nerve cells and loss of motor functions, often resulting in death within 2 to 5 years of diagnosis. Preliminary study results have shown that this treatment, which relies on antisense nucleic acids, led to improvements in the symptoms of a patient with a rare form of the disease, including a reduction in the levels of proteins associated with the damaged nerve cells and improvements in motor and respiratory functions over the course of a year. Researchers hope that this therapy will pave the way for developing more effective treatment strategies for neurodegenerative diseases linked to rare genetic mutations, though longer-term follow-up on a larger number of patients is necessary to confirm these benefits.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)